EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma

Ming Zhang, Zhi-Qiang Xiao, Wei Huang, Shan-Shan Lu, Hong Yi, Juan Feng iD

Cancer Science · 2025

DOI: 10.1111/cas.70291 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Ming Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Radiation Tolerance, Nasopharyngeal Carcinoma, Receptor, EphA2, Nasopharyngeal Neoplasms. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province, Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nasopharyngeal carcinoma (NPC) is a malignant tumor characterized by significant radioresistance and poor clinical outcomes. EphA2, a protein frequently overexpressed in various malignancies, has been implicated in promoting tumor growth and metastasis. This study explored the role and mechanism of EphA2 in driving radioresistance in NPC and evaluated the therapeutic potential of the A11 peptide in overcoming this resistance. Clinical analysis of 104 NPC tissues (26 radioresistant and 78 radiosensitive) revealed that high EphA2 expression was significantly associated with radioresistance and independently predicted reduced overall survival. Functional studies using EphA2‐knockdown NPC cell lines (5‐8F and CNE2) demonstrated that silencing EphA2 enhanced radiosensitivity, as evidenced by in vitro assays including clonogenic formation, apoptosis analysis, and γ‐H2AX detection, as well as in vivo xenograft experiments. Mechanistically, EphA2 drives radioresistance through a radiation‐induced RSK‐EphA2‐AKT signaling cascade. Specifically, radiation triggered RSK‐mediated phosphorylation of EphA2 at Ser897, which subsequently facilitated AKT phosphorylation at Ser473. The A11 peptide broke this signaling cascade by degrading EphA2 and blocking its S897 phosphorylation, thereby markedly enhancing radiosensitivity. These findings indicate that EphA2 overexpression and its S897 phosphorylation play a critical role in NPC radioresistance. The A11 peptide emerges as a promising therapeutic agent by degrading EphA2 and blocking its phosphorylation, offering a potential strategy to enhance radiotherapy efficacy and improve outcomes in NPC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiation ToleranceNasopharyngeal CarcinomaReceptor, EphA2Nasopharyngeal NeoplasmsEphrin-A2HumansCell Line, TumorAnimalsMiceFemalePhosphorylationMaleXenograft Model Antitumor AssaysSignal TransductionApoptosisProto-Oncogene Proteins c-aktMiddle AgedMice, Nude

Stichwörter der Autor:innen

A11 peptideEphA2EphA2 S897 phosphorylationnasopharyngeal carcinomaradiosensitivity

Substanzen

Receptor, EphA2EPHA2 protein, humanProto-Oncogene Proteins c-aktEphrin-A2

Autor:innen und Institutionen

  • Research Center of Carcinogenesis and Targeted Therapy, Xiangya Hospital, Central South University, Changsha, China.
  • The Higher Educational Key Laboratory for Cancer Proteomics and Translational Medicine of Hunan Province, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Pathology, the Second Xiangya Hospital, Central South University, Changsha, China.

ORCID-Profile: Juan Feng

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Hunan Province
  • Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University
  • Scientific Research Fund of Hunan Provincial Education Department

Zitieren

APA

Zhang, M., Xiao, Z. Q., Huang, W., Lu, S. S., Yi, H., & Feng, J. (2025). A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma. Cancer Science. https://doi.org/10.1111/cas.70291

Vancouver

Zhang M, Xiao ZQ, Huang W, Lu SS, Yi H, Feng J. A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma. Cancer Science. 2025. doi:10.1111/cas.70291

BibTeX
@article{Zhang2025,
  author = {Zhang, Ming and Xiao, Zhi-Qiang and Huang, Wei and Lu, Shan-Shan and Yi, Hong and Feng, Juan},
  title = {A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma},
  journal = {Cancer Science},
  year = {2025},
  doi = {10.1111/cas.70291}
}
Kostenlos starten →